Publications published since 1999 from OUS - Translational Cancer Therapy

162 publications found

Publications 2020

1. Aghayan DL, Kazaryan AM, Dagenborg VJ, Røsok BI, Fagerland MW, Bjørnelv GMW, Kristiansen R, Flatmark K, Fretland ÅA, Edwin B (2020)
   Long-Term Oncologic Outcomes After Laparoscopic Versus Open Resection for Colorectal Liver Metastases : A Randomized Trial
   Ann Intern Med (in press)
   DOI 10.7326/M20-4011, PubMed 33197213
2. Chen B, Dragomir MP, Fabris L, Bayraktar R, Knutsen E, Liu X, Tang C, Li Y, Shimura T, Ivkovic TC, Cruz De Los Santos M, Anfossi S, Shimizu M, Shah MY, Ling H, Shen P, Multani AS, Pardini B, Burks JK, Katayama H, Reineke LC, Huo L, Syed M, Song S, Ferracin M et al. (2020)
   The Long Noncoding RNA CCAT2 Induces Chromosomal Instability Through BOP1-AURKB Signaling
   Gastroenterology, 159 (6), 2146-2162.e33
   DOI 10.1053/j.gastro.2020.08.018, PubMed 32805281
3. Dagenborg VJ, Marshall SE, Yaqub S, Grzyb K, Boye K, Lund-Iversen M, Høye E, Berstad AE, Fretland ÅA, Edwin B, Ree AH, Flatmark K (2020)
   Neoadjuvant chemotherapy is associated with a transient increase of intratumoral T-cell density in microsatellite stable colorectal liver metastases
   Cancer Biol Ther, 21 (5), 432-440
   DOI 10.1080/15384047.2020.1721252, PubMed 32098573
4. De Las Heras J, Diez I, Jimenez-Marin A, Cabrera A, Ramos-Usuga D, Diaz-Fernandez MV, Torices L, Nunes-Xavier CE, Pulido R, Arango-Lasprilla JC, Cortes JM (2020)
   Brain Circuit Alterations and Cognitive Disability in Late-Onset Cobalamin D Disorder
   J Clin Med, 9 (4)
   DOI 10.3390/jcm9040990, PubMed 32252256
5. Flatmark K, Mohamed F (2020)
   ASO Author Reflections: Estimating the Prevalence of Pseudomyxoma Peritonei in Europe Using a Novel Statistical Method
   Ann Surg Oncol, 27 (Suppl 3), 771-772
   DOI 10.1245/s10434-020-08691-4, PubMed 32495284
6. Flem-Karlsen K, Fodstad Ø, Nunes-Xavier CE (2020)
   B7-H3 Immune Checkpoint Protein in Human Cancer
   Curr Med Chem, 27 (24), 4062-4086
   DOI 10.2174/0929867326666190517115515, PubMed 31099317
7. Fleten KG, Lund-Andersen C, Waagene S, Abrahamsen TW, Mørch Y, Boye K, Torgunrud A, Flatmark K (2020)
   Experimental Treatment of Mucinous Peritoneal Metastases Using Patient-Derived Xenograft Models
   Transl Oncol, 13 (8), 100793
   DOI 10.1016/j.tranon.2020.100793, PubMed 32447231
8. Fromm B, Domanska D, Høye E, Ovchinnikov V, Kang W, Aparicio-Puerta E, Johansen M, Flatmark K, Mathelier A, Hovig E, Hackenberg M, Friedländer MR, Peterson KJ (2020)
   MirGeneDB 2.0: the metazoan microRNA complement
   Nucleic Acids Res, 48 (D1), D1172
   DOI 10.1093/nar/gkz1016, PubMed 31642479
9. Fromm B, Domanska D, Høye E, Ovchinnikov V, Kang W, Aparicio-Puerta E, Johansen M, Flatmark K, Mathelier A, Hovig E, Hackenberg M, Friedländer MR, Peterson KJ (2020)
   MirGeneDB 2.0: the metazoan microRNA complement
   Nucleic Acids Res, 48 (D1), D132-D141
   DOI 10.1093/nar/gkz885, PubMed 31598695
10. Meltzer S, Bjørnetrø T, Lyckander LG, Flatmark K, Dueland S, Samiappan R, Johansen C, Kalanxhi E, Ree AH, Redalen KR (2020)
    Corrigendum to "Circulating Exosomal miR-141-3p and miR-375 in Metastatic Progression of Rectal Cancer" [Transl Oncol 12 (8) (2019) 1038-1044]
    Transl Oncol, 13 (1), 122-124
    DOI 10.1016/j.tranon.2019.09.005, PubMed 31843135
11. Patrick-Brown TDJH, Carr NJ, Swanson DM, Larsen S, Mohamed F, Flatmark K (2020)
    Estimating the Prevalence of Pseudomyxoma Peritonei in Europe Using a Novel Statistical Method
    Ann Surg Oncol, 28 (1), 252-257
    DOI 10.1245/s10434-020-08655-8, PubMed 32488520
12. Ree AH, Nygaard V, Boye K, Heinrich D, Dueland S, Bergheim IR, Johansen C, Beiske K, Negård A, Lund-Iversen M, Nygaard V, Hovig E, Nakken S, Nasser S, Julsrud L, Reisse CH, Ruud EA, Kristensen VN, Flørenes VA, Geitvik GA, Lingjærde OC, Børresen-Dale AL, Russnes HG, Mælandsmo GM, Flatmark K (2020)
    Molecularly matched therapy in the context of sensitivity, resistance, and safety; patient outcomes in end-stage cancer - the MetAction study
    Acta Oncol, 59 (7), 733-740
    DOI 10.1080/0284186X.2020.1742377, PubMed 32208873
13. Saeednejad Zanjani L, Madjd Z, Axcrona U, Abolhasani M, Rasti A, Asgari M, Fodstad Ø, Andersson Y (2020)
    Cytoplasmic expression of B7-H3 and membranous EpCAM expression are associated with higher grade and survival outcomes in patients with clear cell renal cell carcinoma
    Ann Diagn Pathol, 46, 151483
    DOI 10.1016/j.anndiagpath.2020.151483, PubMed 32143173

Publications 2019

1. Abrahamsson H, Porojnicu AC, Lindstrøm JC, Dueland S, Flatmark K, Hole KH, Seierstad T, Moan J, Redalen KR, Meltzer S, Ree AH (2019)
   High level of circulating vitamin D during neoadjuvant therapy may lower risk of metastatic progression in high-risk rectal cancer
   BMC Cancer, 19 (1), 488
   DOI 10.1186/s12885-019-5724-z, PubMed 31122213
2. Aghayan DL, Fretland ÅA, Kazaryan AM, Sahakyan MA, Dagenborg VJ, Bjørnbeth BA, Flatmark K, Kristiansen R, Edwin B (2019)
   Laparoscopic versus open liver resection in the posterosuperior segments: a sub-group analysis from the OSLO-COMET randomized controlled trial
   HPB (Oxford), 21 (11), 1485-1490
   DOI 10.1016/j.hpb.2019.03.358, PubMed 30962136
3. Andersson Y, Inderberg EM, Kvalheim G, Herud TM, Engebraaten O, Flatmark K, Dueland S, Fodstad Ø (2019)
   Immune stimulatory effect of anti-EpCAM immunotoxin - improved overall survival of metastatic colorectal cancer patients
   Acta Oncol, 59 (4), 404-409
   DOI 10.1080/0284186X.2019.1704864, PubMed 31876430
4. Bains SJ, Abrahamsson H, Flatmark K, Dueland S, Hole KH, Seierstad T, Redalen KR, Meltzer S, Ree AH (2019)
   Immunogenic cell death by neoadjuvant oxaliplatin and radiation protects against metastatic failure in high-risk rectal cancer
   Cancer Immunol Immunother, 69 (3), 355-364
   DOI 10.1007/s00262-019-02458-x, PubMed 31893287
5. Brudvik KW, Jones RP, Giuliante F, Shindoh J, Passot G, Chung MH, Song J, Li L, Dagenborg VJ, Fretland ÅA, Røsok B, De Rose AM, Ardito F, Edwin B, Panettieri E, Larocca LM, Yamashita S, Conrad C, Aloia TA, Poston GJ, Bjørnbeth BA, Vauthey JN (2019)
   RAS Mutation Clinical Risk Score to Predict Survival After Resection of Colorectal Liver Metastases
   Ann Surg, 269 (1), 120-126
   DOI 10.1097/SLA.0000000000002319, PubMed 28549012
6. Calvete J, Larrinaga G, Errarte P, Martín AM, Dotor A, Esquinas C, Nunes-Xavier CE, Pulido R, López JI, Angulo JC (2019)
   The coexpression of fibroblast activation protein (FAP) and basal-type markers (CK 5/6 and CD44) predicts prognosis in high-grade invasive urothelial carcinoma of the bladder
   Hum Pathol, 91, 61-68
   DOI 10.1016/j.humpath.2019.07.002, PubMed 31279874
7. Flem-Karlsen K, Tekle C, Øyjord T, Flørenes VA, Mælandsmo GM, Fodstad Ø, Nunes-Xavier CE (2019)
   p38 MAPK activation through B7-H3-mediated DUSP10 repression promotes chemoresistance
   Sci Rep, 9 (1), 5839
   DOI 10.1038/s41598-019-42303-w, PubMed 30967582
8. Flørenes VA, Flem-Karlsen K, McFadden E, Bergheim IR, Nygaard V, Nygård V, Farstad IN, Øy GF, Emilsen E, Giller-Fleten K, Ree AH, Flatmark K, Gullestad HP, Hermann R, Ryder T, Wernhoff P, Mælandsmo GM (2019)
   A Three-dimensional Ex Vivo Viability Assay Reveals a Strong Correlation Between Response to Targeted Inhibitors and Mutation Status in Melanoma Lymph Node Metastases
   Transl Oncol, 12 (7), 951-958
   DOI 10.1016/j.tranon.2019.04.001, PubMed 31096111
9. Fretland ÅA, Dagenborg VJ, Waaler Bjørnelv GM, Aghayan DL, Kazaryan AM, Barkhatov L, Kristiansen R, Fagerland MW, Edwin B, Andersen MH (2019)
   Quality of life from a randomized trial of laparoscopic or open liver resection for colorectal liver metastases
   Br J Surg, 106 (10), 1372-1380
   DOI 10.1002/bjs.11227, PubMed 31322735
10. Frøysnes IS, Andersson Y, Larsen SG, Davidson B, Øien JT, Julsrud L, Fodstad Ø, Dueland S, Flatmark K (2019)
    ImmunoPeCa trial: Long-term outcome following intraperitoneal MOC31PE immunotoxin treatment in colorectal peritoneal metastasis
    Eur J Surg Oncol, 47 (1), 134-138
    DOI 10.1016/j.ejso.2019.04.014, PubMed 31036394
11. Hansen EP, Fromm B, Andersen SD, Marcilla A, Andersen KL, Borup A, Williams AR, Jex AR, Gasser RB, Young ND, Hall RS, Stensballe A, Ovchinnikov V, Yan Y, Fredholm M, Thamsborg SM, Nejsum P (2019)
    Exploration of extracellular vesicles from Ascaris suum provides evidence of parasite-host cross talk
    J Extracell Vesicles, 8 (1), 1578116
    DOI 10.1080/20013078.2019.1578116, PubMed 30815237
12. Hausken J, Fretland ÅA, Edwin B, Andersen MH, Dagenborg VJ, Bjørnelv GMW, Kristiansen R, Røysland K, Kvarstein G, Tønnessen TI (2019)
    Intravenous Patient-controlled Analgesia Versus Thoracic Epidural Analgesia After Open Liver Surgery: A Prospective, Randomized, Controlled, Noninferiority Trial
    Ann Surg, 270 (2), 193-199
    DOI 10.1097/SLA.0000000000003209, PubMed 30676382
13. Lund-Andersen C, Nakken S, Nygård S, Fromm B, Aasheim LB, Davidson B, Julsrud L, Abrahamsen TW, Kristensen AT, Dybdahl B, Larsen SG, Hovig E, Flatmark K (2019)
    Integrative genomic analysis of peritoneal malignant mesothelioma: understanding a case with extraordinary chemotherapy response
    Cold Spring Harb Mol Case Stud, 5 (2)
    DOI 10.1101/mcs.a003566, PubMed 30862609
14. Meltzer S, Bakke KM, Rød KL, Negård A, Flatmark K, Solbakken AM, Kristensen AT, Fuglestad AJ, Kersten C, Dueland S, Seierstad T, Hole KH, Lyckander LG, Larsen FO, Schou JV, Patrick Brown D, Abrahamsson H, Redalen KR, Ree AH (2019)
    Sex-related differences in primary metastatic site in rectal cancer; associated with hemodynamic factors?
    Clin Transl Radiat Oncol, 21, 5-10
    DOI 10.1016/j.ctro.2019.11.006, PubMed 31872084
15. Meltzer S, Bjørnetrø T, Lyckander LG, Flatmark K, Dueland S, Samiappan R, Johansen C, Kalanxhi E, Ree AH, Redalen KR (2019)
    Circulating Exosomal miR-141-3p and miR-375 in Metastatic Progression of Rectal Cancer
    Transl Oncol, 12 (8), 1038-1044
    DOI 10.1016/j.tranon.2019.04.014, PubMed 31146167
16. Mingo J, Luna S, Gaafar A, Nunes-Xavier CE, Torices L, Mosteiro L, Ruiz R, Guerra I, Llarena R, Angulo JC, López JI, Pulido R (2019)
    Precise definition of PTEN C-terminal epitopes and its implications in clinical oncology
    NPJ Precis Oncol, 3, 11
    DOI 10.1038/s41698-019-0083-4, PubMed 30993208
17. Nunes-Xavier CE, Angulo JC, Pulido R, López JI (2019)
    A Critical Insight into the Clinical Translation of PD-1/PD-L1 Blockade Therapy in Clear Cell Renal Cell Carcinoma
    Curr Urol Rep, 20 (1), 1
    DOI 10.1007/s11934-019-0866-8, PubMed 30645700
18. Nunes-Xavier CE, Aurtenetxe O, Zaldumbide L, López-Almaraz R, Erramuzpe A, Cortés JM, López JI, Pulido R (2019)
    Protein tyrosine phosphatase PTPN1 modulates cell growth and associates with poor outcome in human neuroblastoma
    Diagn Pathol, 14 (1), 134
    DOI 10.1186/s13000-019-0919-9, PubMed 31837707
19. Nunes-Xavier CE, Zaldumbide L, Aurtenetxe O, López-Almaraz R, López JI, Pulido R (2019)
    Dual-Specificity Phosphatases in Neuroblastoma Cell Growth and Differentiation
    Int J Mol Sci, 20 (5)
    DOI 10.3390/ijms20051170, PubMed 30866462
20. Pulido R, Mingo J, Gaafar A, Nunes-Xavier CE, Luna S, Torices L, Angulo JC, López JI (2019)
    Precise Immunodetection of PTEN Protein in Human Neoplasia
    Cold Spring Harb Perspect Med, 9 (12)
    DOI 10.1101/cshperspect.a036293, PubMed 31501265
21. Ree AH, Nygaard V, Russnes HG, Heinrich D, Nygaard V, Johansen C, Bergheim IR, Hovig E, Beiske K, Negård A, Børresen-Dale AL, Flatmark K, Mælandsmo GM (2019)
    Responsiveness to PD-1 Blockade in End-Stage Colon Cancer with Gene Locus 9p24.1 Copy-Number Gain
    Cancer Immunol Res, 7 (5), 701-706
    DOI 10.1158/2326-6066.CIR-18-0777, PubMed 30804006
22. Saeednejad Zanjani L, Madjd Z, Rasti A, Asgari M, Abolhasani M, Tam KJ, Roudi R, Mælandsmo GM, Fodstad Ø, Andersson Y (2019)
    Spheroid-Derived Cells From Renal Adenocarcinoma Have Low Telomerase Activity and High Stem-Like and Invasive Characteristics
    Front Oncol, 9, 1302
    DOI 10.3389/fonc.2019.01302, PubMed 31921617
23. Sørensen O, Andersen AM, Larsen SG, Giercksky KE, Flatmark K (2019)
    Intraperitoneal mitomycin C improves survival compared to cytoreductive surgery alone in an experimental model of high-grade pseudomyxoma peritonei
    Clin Exp Metastasis, 36 (6), 511-518
    DOI 10.1007/s10585-019-09991-0, PubMed 31541325

Publications 2018

1. Aurtenetxe O, Zaldumbide L, Erramuzpe A, López R, López JI, Cortés JM, Pulido R, Nunes-Xavier CE (2018)
   DUSP5 expression associates with poor prognosis in human neuroblastoma
   Exp Mol Pathol, 105 (3), 272-278
   DOI 10.1016/j.yexmp.2018.08.008, PubMed 30171833
2. Bousquet PA, Meltzer S, Sønstevold L, Esbensen Y, Dueland S, Flatmark K, Sitter B, Bathen TF, Seierstad T, Redalen KR, Eide L, Ree AH (2018)
   Markers of Mitochondrial Metabolism in Tumor Hypoxia, Systemic Inflammation, and Adverse Outcome of Rectal Cancer
   Transl Oncol, 12 (1), 76-83
   DOI 10.1016/j.tranon.2018.09.010, PubMed 30273860
3. Bråte J, Neumann RS, Fromm B, Haraldsen AAB, Tarver JE, Suga H, Donoghue PCJ, Peterson KJ, Ruiz-Trillo I, Grini PE, Shalchian-Tabrizi K (2018)
   Unicellular Origin of the Animal MicroRNA Machinery
   Curr Biol, 28 (20), 3288-3295.e5
   DOI 10.1016/j.cub.2018.08.018, PubMed 30318349
4. Flem-Karlsen K, Fodstad Ø, Tan M, Nunes-Xavier CE (2018)
   B7-H3 in Cancer - Beyond Immune Regulation
   Trends Cancer, 4 (6), 401-404
   DOI 10.1016/j.trecan.2018.03.010, PubMed 29860983
5. Fretland ÅA, Dagenborg VJ, Bjørnelv GMW, Kazaryan AM, Kristiansen R, Fagerland MW, Hausken J, Tønnessen TI, Abildgaard A, Barkhatov L, Yaqub S, Røsok BI, Bjørnbeth BA, Andersen MH, Flatmark K, Aas E, Edwin B (2018)
   Laparoscopic Versus Open Resection for Colorectal Liver Metastases: The OSLO-COMET Randomized Controlled Trial
   Ann Surg, 267 (2), 199-207
   DOI 10.1097/SLA.0000000000002353, PubMed 28657937
6. Fromm B, Kang W, Rovira C, Cayota A, Witwer K, Friedländer MR, Tosar JP (2018)
   Plant microRNAs in human sera are likely contaminants
   J Nutr Biochem, 65, 139-140
   DOI 10.1016/j.jnutbio.2018.07.019, PubMed 30266285
7. Fromm B, Tosar JP, Lu Y, Halushka MK, Witwer KW (2018)
   Human and Cow Have Identical miR-21-5p and miR-30a-5p Sequences, Which Are Likely Unsuited to Study Dietary Uptake from Cow Milk
   J Nutr, 148 (9), 1506-1507
   DOI 10.1093/jn/nxy144, PubMed 30184228
8. Fusser M, Øverbye A, Pandya AD, Mørch Ý, Borgos SE, Kildal W, Snipstad S, Sulheim E, Fleten KG, Askautrud HA, Engebraaten O, Flatmark K, Iversen TG, Sandvig K, Skotland T, Mælandsmo GM (2018)
   Cabazitaxel-loaded Poly(2-ethylbutyl cyanoacrylate) nanoparticles improve treatment efficacy in a patient derived breast cancer xenograft
   J Control Release, 293, 183-192
   DOI 10.1016/j.jconrel.2018.11.029, PubMed 30529259
9. Halushka MK, Fromm B, Peterson KJ, McCall MN (2018)
   Big Strides in Cellular MicroRNA Expression
   Trends Genet, 34 (3), 165-167
   DOI 10.1016/j.tig.2017.12.015, PubMed 29361313
10. Kalanxhi E, Meltzer S, Schou JV, Larsen FO, Dueland S, Flatmark K, Jensen BV, Hole KH, Seierstad T, Redalen KR, Nielsen DL, Ree AH (2018)
    Systemic immune response induced by oxaliplatin-based neoadjuvant therapy favours survival without metastatic progression in high-risk rectal cancer
    Br J Cancer, 118 (10), 1322-1328
    DOI 10.1038/s41416-018-0085-y, PubMed 29695770
11. Mariathasan AB, Boye K, Giercksky KE, Brennhovd B, Gullestad HP, Emblemsvåg HL, Grøholt KK, Dueland S, Flatmark K, Larsen SG (2018)
    Beyond total mesorectal excision in locally advanced rectal cancer with organ or pelvic side-wall involvement
    Eur J Surg Oncol, 44 (8), 1226-1232
    DOI 10.1016/j.ejso.2018.03.029, PubMed 29691115
12. Mikalsen SG, Mikalsen LTG, Sandvik JA, Aarnes EK, Fenne S, Flatmark K, Lyng H, Edin NFJ, Pettersen EO (2018)
    Low dose-rate irradiation with [³H]-labelled valine to selectively target hypoxic cells in a human colorectal cancer xenograft model
    Acta Oncol, 57 (9), 1216-1224
    DOI 10.1080/0284186X.2018.1457223, PubMed 29630428
13. Nunes-Xavier CE, Mingo J, López JI, Pulido R (2018)
    The role of protein tyrosine phosphatases in prostate cancer biology
    Biochim Biophys Acta Mol Cell Res, 1866 (1), 102-113
    DOI 10.1016/j.bbamcr.2018.06.016, PubMed 30401533
14. Saeednejad Zanjani L, Madjd Z, Abolhasani M, Rasti A, Shariftabrizi A, Mehrazma M, Fodstad Ø, Asgari M (2018)
    Human telomerase reverse transcriptase protein expression predicts tumour aggressiveness and survival in patients with clear cell renal cell carcinoma
    Pathology, 51 (1), 21-31
    DOI 10.1016/j.pathol.2018.08.019, PubMed 30466948
15. Spasojevic M, Mariathasan AB, Goscinski M, Thorgersen EB, Solbakken AM, Gullestad HP, Ryder T, Flatmark K, Larsen SG (2018)
    Vertical Rectus Abdominis Musculocutaneous Flap Repair Improves Perineal Wound Healing after Abdominoperineal Resection for Irradiated Locally Advanced Rectal Cancer
    Ann Surg Oncol, 25 (5), 1357-1365
    DOI 10.1245/s10434-018-6363-3, PubMed 29497909
16. Tarver JE, Taylor RS, Puttick MN, Lloyd GT, Pett W, Fromm B, Schirrmeister BE, Pisani D, Peterson KJ, Donoghue PCJ (2018)
    Well-Annotated microRNAomes Do Not Evidence Pervasive miRNA Loss
    Genome Biol Evol, 10 (6), 1457-1470
    DOI 10.1093/gbe/evy096, PubMed 29788279

Publications 2017

1. Andersson Y, Haavardtun SI, Davidson B, Dørum A, Fleten KG, Fodstad Ø, Flatmark K (2017)
   MOC31PE immunotoxin - targeting peritoneal metastasis from epithelial ovarian cancer
   Oncotarget, 8 (37), 61800-61809
   DOI 10.18632/oncotarget.18694, PubMed 28977905
2. Arstad C, Refinetti P, Kristensen AT, Giercksky KE, Ekstrøm PO (2017)
   Is detection of intraperitoneal exfoliated tumor cells after surgical resection of rectal cancer a prognostic factor of survival?
   BMC Cancer, 17 (1), 406
   DOI 10.1186/s12885-017-3365-7, PubMed 28592327
3. Bakke KM, Hole KH, Dueland S, Grøholt KK, Flatmark K, Ree AH, Seierstad T, Redalen KR (2017)
   Diffusion-weighted magnetic resonance imaging of rectal cancer: tumour volume and perfusion fraction predict chemoradiotherapy response and survival
   Acta Oncol, 56 (6), 813-818
   DOI 10.1080/0284186X.2017.1287951, PubMed 28464745
4. Egger B, Bachmann L, Fromm B (2017)
   Atp8 is in the ground pattern of flatworm mitochondrial genomes
   BMC Genomics, 18 (1), 414
   DOI 10.1186/s12864-017-3807-2, PubMed 28549457
5. Eide N, Faye RS, Høifødt HK, Sandvik L, Qvale GA, Faber R, Jebsen P, Kvalheim G, Fodstad Ø (2017)
   The Results of Stricter Inclusion Criteria in an Immunomagnetic Detection Study of Micrometastatic Cells in Bone Marrow of Uveal Melanoma Patients - Relevance for Dormancy
   Pathol Oncol Res, 25 (1), 255-262
   DOI 10.1007/s12253-017-0355-7, PubMed 29098521
6. Flem-Karlsen K, Tekle C, Andersson Y, Flatmark K, Fodstad Ø, Nunes-Xavier CE (2017)
   Immunoregulatory protein B7-H3 promotes growth and decreases sensitivity to therapy in metastatic melanoma cells
   Pigment Cell Melanoma Res, 30 (5), 467-476
   DOI 10.1111/pcmr.12599, PubMed 28513992
7. Frøysnes IS, Andersson Y, Larsen SG, Davidson B, Øien JT, Olsen KH, Giercksky KE, Julsrud L, Fodstad Ø, Dueland S, Flatmark K (2017)
   Novel Treatment with Intraperitoneal MOC31PE Immunotoxin in Colorectal Peritoneal Metastasis: Results From the ImmunoPeCa Phase 1 Trial
   Ann Surg Oncol, 24 (7), 1916-1922
   DOI 10.1245/s10434-017-5814-6, PubMed 28224367
8. Graudenzi A, Cava C, Bertoli G, Fromm B, Flatmark K, Mauri G, Castiglioni I (2017)
   Pathway-based classification of breast cancer subtypes
   Front Biosci (Landmark Ed), 22, 1697-1712
   DOI 10.2741/4566, PubMed 28410140
9. Lim S, Phillips JB, Madeira da Silva L, Zhou M, Fodstad O, Owen LB, Tan M (2017)
   Interplay between Immune Checkpoint Proteins and Cellular Metabolism
   Cancer Res, 77 (6), 1245-1249
   DOI 10.1158/0008-5472.CAN-16-1647, PubMed 28246276
10. Østrup O, Dagenborg VJ, Rødland EA, Skarpeteig V, Silwal-Pandit L, Grzyb K, Berstad AE, Fretland ÅA, Mælandsmo GM, Børresen-Dale AL, Ree AH, Edwin B, Nygaard V, Flatmark K (2017)
    Molecular signatures reflecting microenvironmental metabolism and chemotherapy-induced immunogenic cell death in colorectal liver metastases
    Oncotarget, 8 (44), 76290-76304
    DOI 10.18632/oncotarget.19350, PubMed 29100312
11. Ovchinnikov VY, Mordvinov VA, Fromm B (2017)
    Extreme conservation of miRNA complements in opisthorchiids
    Parasitol Int, 66 (6), 773-776
    DOI 10.1016/j.parint.2017.09.006, PubMed 28916307
12. Øverbye A, Holsæter AM, Markus F, Škalko-Basnet N, Iversen TG, Torgersen ML, Sønstevold T, Engebraaten O, Flatmark K, Mælandsmo GM, Skotland T, Sandvig K (2017)
    Ceramide-containing liposomes with doxorubicin: time and cell-dependent effect of C6 and C12 ceramide
    Oncotarget, 8 (44), 76921-76934
    DOI 10.18632/oncotarget.20217, PubMed 29100358
13. Ree AH, Russnes HG, Heinrich D, Dueland S, Boye K, Nygaard V, Silwal-Pandit L, Østrup O, Hovig E, Nygaard V, Rødland EA, Nakken S, Øien JT, Johansen C, Bergheim IR, Skarpeteig V, Sathermugathevan M, Sauer T, Lund-Iversen M, Beiske K, Nasser S, Julsrud L, Reisse CH, Ruud EA, Flørenes VA et al. (2017)
    Implementing precision cancer medicine in the public health services of Norway: the diagnostic infrastructure and a cost estimate
    ESMO Open, 2 (2), e000158
    DOI 10.1136/esmoopen-2017-000158, PubMed 28761742
14. Saeednejad Zanjani L, Madjd Z, Abolhasani M, Andersson Y, Rasti A, Shariftabrizi A, Asgari M (2017)
    Cytoplasmic expression of CD133 stemness marker is associated with tumor aggressiveness in clear cell renal cell carcinoma
    Exp Mol Pathol, 103 (2), 218-228
    DOI 10.1016/j.yexmp.2017.10.001, PubMed 29050853
15. Simovski B, Vodák D, Gundersen S, Domanska D, Azab A, Holden L, Holden M, Grytten I, Rand K, Drabløs F, Johansen M, Mora A, Lund-Andersen C, Fromm B, Eskeland R, Gabrielsen OS, Ferkingstad E, Nakken S, Bengtsen M, Nederbragt AJ, Thorarensen HS, Akse JA, Glad I, Hovig E, Sandve GK (2017)
    GSuite HyperBrowser: integrative analysis of dataset collections across the genome and epigenome
    Gigascience, 6 (7), 1-12
    DOI 10.1093/gigascience/gix032, PubMed 28459977
16. Umu SU, Langseth H, Bucher-Johannessen C, Fromm B, Keller A, Meese E, Lauritzen M, Leithaug M, Lyle R, Rounge TB (2017)
    A comprehensive profile of circulating RNAs in human serum
    RNA Biol, 15 (2), 242-250
    DOI 10.1080/15476286.2017.1403003, PubMed 29219730
17. Wang MY, Nestvold J, Rekdal Ø, Kvalheim G, Fodstad Ø (2017)
    A novel rat fibrosarcoma cell line from transformed bone marrow-derived mesenchymal stem cells with maintained in vitro and in vivo stemness properties
    Exp Cell Res, 352 (2), 218-224
    DOI 10.1016/j.yexcr.2017.02.005, PubMed 28189639
18. Zanjani LS, Madjd Z, Abolhasani M, Rasti A, Fodstad O, Andersson Y, Asgari M (2017)
    Increased expression of CD44 is associated with more aggressive behavior in clear cell renal cell carcinoma
    Biomark Med, 12 (1), 45-61
    DOI 10.2217/bmm-2017-0142, PubMed 29243496

Publications 2016

1. Alonso A, Nunes-Xavier CE, Bayón Y, Pulido R (2016)
   The Extended Family of Protein Tyrosine Phosphatases
   Methods Mol Biol, 1447, 1-23
   DOI 10.1007/978-1-4939-3746-2_1, PubMed 27514797
2. Bachmann L, Fromm B, Patella de Azambuja L, Boeger WA (2016)
   The mitochondrial genome of the egg-laying flatworm Aglaiogyrodactylus forficulatus (Platyhelminthes: Monogenoidea)
   Parasit Vectors, 9 (1), 285
   DOI 10.1186/s13071-016-1586-2, PubMed 27188228
3. Boye K, Jacob H, Frikstad KA, Nesland JM, Maelandsmo GM, Dahl O, Nesbakken A, Flatmark K (2016)
   Prognostic significance of S100A4 expression in stage II and III colorectal cancer: results from a population-based series and a randomized phase III study on adjuvant chemotherapy
   Cancer Med, 5 (8), 1840-9
   DOI 10.1002/cam4.766, PubMed 27273130
4. Dueland S, Ree AH, Grøholt KK, Saelen MG, Folkvord S, Hole KH, Seierstad T, Larsen SG, Giercksky KE, Wiig JN, Boye K, Flatmark K (2016)
   Oxaliplatin-containing Preoperative Therapy in Locally Advanced Rectal Cancer: Local Response, Toxicity and Long-term Outcome
   Clin Oncol (R Coll Radiol), 28 (8), 532-9
   DOI 10.1016/j.clon.2016.01.014, PubMed 26888115
5. Egeland EV, Flatmark K, Nesland JM, Flørenes VA, Mælandsmo GM, Boye K (2016)
   Expression and clinical significance of Wee1 in colorectal cancer
   Tumour Biol, 37 (9), 12133-12140
   DOI 10.1007/s13277-016-5081-3, PubMed 27220319
6. Errarte P, Guarch R, Pulido R, Blanco L, Nunes-Xavier CE, Beitia M, Gil J, Angulo JC, López JI, Larrinaga G (2016)
   The Expression of Fibroblast Activation Protein in Clear Cell Renal Cell Carcinomas Is Associated with Synchronous Lymph Node Metastases
   PLoS One, 11 (12), e0169105
   DOI 10.1371/journal.pone.0169105, PubMed 28033421
7. Flatmark K, Høye E, Fromm B (2016)
   microRNAs as cancer biomarkers
   Scand J Clin Lab Invest Suppl, 245, S80-3
   DOI 10.1080/00365513.2016.1210330, PubMed 27542003
8. Flatmark K, Saelen MG, Hole KH, Abrahamsen TW, Fleten KG, Hektoen HH, Redalen KR, Seierstad T, Dueland S, Ree AH (2016)
   Individual tumor volume responses to short-course oxaliplatin-containing induction chemotherapy in locally advanced rectal cancer - Targeting the tumor for radiation sensitivity?
   Radiother Oncol, 119 (3), 505-11
   DOI 10.1016/j.radonc.2016.02.020, PubMed 26968754
9. Fleten KG, Bakke KM, Mælandsmo GM, Abildgaard A, Redalen KR, Flatmark K (2016)
   Use of non-invasive imaging to monitor response to aflibercept treatment in murine models of colorectal cancer liver metastases
   Clin Exp Metastasis, 34 (1), 51-62
   DOI 10.1007/s10585-016-9829-3, PubMed 27812769
10. Fleten KG, Flørenes VA, Prasmickaite L, Hill O, Sykora J, Mælandsmo GM, Engesæter B (2016)
    hvTRA, a novel TRAIL receptor agonist, induces apoptosis and sustained growth retardation in melanoma
    Cell Death Discov, 2, 16081
    DOI 10.1038/cddiscovery.2016.81, PubMed 28028438
11. Frøysnes IS, Larsen SG, Spasojevic M, Dueland S, Flatmark K (2016)
    Complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastasis in Norway: Prognostic factors and oncologic outcome in a national patient cohort
    J Surg Oncol, 114 (2), 222-7
    DOI 10.1002/jso.24290, PubMed 27173150
12. Haakensen VD, Nygaard V, Greger L, Aure MR, Fromm B, Bukholm IR, Lüders T, Chin SF, Git A, Caldas C, Kristensen VN, Brazma A, Børresen-Dale AL, Hovig E, Helland Å (2016)
    Subtype-specific micro-RNA expression signatures in breast cancer progression
    Int J Cancer, 139 (5), 1117-28
    DOI 10.1002/ijc.30142, PubMed 27082076
13. Hompland I, Bruland ØS, Ubhayasekhera K, Bergquist J, Boye K (2016)
    Clinical implications of repeated drug monitoring of imatinib in patients with metastatic gastrointestinal stromal tumour
    Clin Sarcoma Res, 6, 21
    DOI 10.1186/s13569-016-0062-2, PubMed 27999655
14. Jonsson M, Ragnum HB, Julin CH, Yeramian A, Clancy T, Frikstad KM, Seierstad T, Stokke T, Matias-Guiu X, Ree AH, Flatmark K, Lyng H (2016)
    Hypoxia-independent gene expression signature associated with radiosensitisation of prostate cancer cell lines by histone deacetylase inhibition
    Br J Cancer, 115 (8), 929-939
    DOI 10.1038/bjc.2016.278, PubMed 27599042
15. Kalanxhi E, Hektoen HH, Meltzer S, Dueland S, Flatmark K, Ree AH (2016)
    Circulating proteins in response to combined-modality therapy in rectal cancer identified by antibody array screening
    BMC Cancer, 16, 536
    DOI 10.1186/s12885-016-2601-x, PubMed 27461255
16. Kalanxhi E, Risberg K, Barua IS, Dueland S, Waagene S, Andersen SN, Pettersen SJ, Lindvall JM, Redalen KR, Flatmark K, Ree AH (2016)
    Induction of Apoptosis in Intestinal Toxicity to a Histone Deacetylase Inhibitor in a Phase I Study with Pelvic Radiotherapy
    Cancer Res Treat, 49 (2), 374-386
    DOI 10.4143/crt.2016.080, PubMed 27488871
17. Lim S, Liu H, Madeira da Silva L, Arora R, Liu Z, Phillips JB, Schmitt DC, Vu T, McClellan S, Lin Y, Lin W, Piazza GA, Fodstad O, Tan M (2016)
    Immunoregulatory Protein B7-H3 Reprograms Glucose Metabolism in Cancer Cells by ROS-Mediated Stabilization of HIF1α
    Cancer Res, 76 (8), 2231-42
    DOI 10.1158/0008-5472.CAN-15-1538, PubMed 27197253
18. Meltzer S, Kalanxhi E, Hektoen HH, Dueland S, Flatmark K, Redalen KR, Ree AH (2016)
    Systemic release of osteoprotegerin during oxaliplatin-containing induction chemotherapy and favorable systemic outcome of sequential radiotherapy in rectal cancer
    Oncotarget, 7 (23), 34907-17
    DOI 10.18632/oncotarget.8995, PubMed 27145458
19. Nunes-Xavier CE, Karlsen KF, Tekle C, Pedersen C, Øyjord T, Hongisto V, Nesland JM, Tan M, Sahlberg KK, Fodstad Ø (2016)
    Decreased expression of B7-H3 reduces the glycolytic capacity and sensitizes breast cancer cells to AKT/mTOR inhibitors
    Oncotarget, 7 (6), 6891-901
    DOI 10.18632/oncotarget.6902, PubMed 26771843
20. Nunes-Xavier CE, Pulido R (2016)
    Global RT-PCR and RT-qPCR Analysis of the mRNA Expression of the Human PTPome
    Methods Mol Biol, 1447, 25-37
    DOI 10.1007/978-1-4939-3746-2_2, PubMed 27514798
21. Ramalho-Carvalho J, Fromm B, Henrique R, Jerónimo C (2016)
    Deciphering the function of non-coding RNAs in prostate cancer
    Cancer Metastasis Rev, 35 (2), 235-62
    DOI 10.1007/s10555-016-9628-y, PubMed 27221068
22. Rud AK, Boye K, Fodstad Ø, Juell S, Jørgensen LH, Solberg S, Helland Å, Brustugun OT, Mælandsmo GM (2016)
    Detection of disseminated tumor cells in lymph nodes from patients with early stage non-small cell lung cancer
    Diagn Pathol, 11 (1), 50
    DOI 10.1186/s13000-016-0504-4, PubMed 27316334
23. Seip K, Fleten KG, Barkovskaya A, Nygaard V, Haugen MH, Engesæter BØ, Mælandsmo GM, Prasmickaite L (2016)
    Fibroblast-induced switching to the mesenchymal-like phenotype and PI3K/mTOR signaling protects melanoma cells from BRAF inhibitors
    Oncotarget, 7 (15), 19997-20015
    DOI 10.18632/oncotarget.7671, PubMed 26918352
24. Thorgersen EB, Goscinski MA, Spasojevic M, Solbakken AM, Mariathasan AB, Boye K, Larsen SG, Flatmark K (2016)
    Deep Pelvic Surgical Site Infection After Radiotherapy and Surgery for Locally Advanced Rectal Cancer
    Ann Surg Oncol, 24 (3), 721-728
    DOI 10.1245/s10434-016-5621-5, PubMed 27766561
25. Ylla G, Fromm B, Piulachs MD, Belles X (2016)
    The microRNA toolkit of insects
    Sci Rep, 6, 37736
    DOI 10.1038/srep37736, PubMed 27883064

Publications 2015

1. Andersson Y, Engebraaten O, Juell S, Aamdal S, Brunsvig P, Fodstad Ø, Dueland S (2015)
   Phase I trial of EpCAM-targeting immunotoxin MOC31PE, alone and in combination with cyclosporin
   Br J Cancer, 113 (11), 1548-55
   DOI 10.1038/bjc.2015.380, PubMed 26554649
2. Egeland EV, Boye K, Pettersen SJ, Haugen MH, Øyjord T, Malerød L, Flatmark K, Mælandsmo GM (2015)
   Enrichment of nuclear S100A4 during G2/M in colorectal cancer cells: possible association with cyclin B1 and centrosomes
   Clin Exp Metastasis, 32 (8), 755-67
   DOI 10.1007/s10585-015-9742-1, PubMed 26349943
3. Eide N, Garred Ø, Beiske K, Fodstad Ø (2015)
   Bilateral uveal melanomas with different gene expression detected with 7 years interval
   Acta Ophthalmol, 94 (1), 99-102
   DOI 10.1111/aos.12857, PubMed 26496992
4. Fretland ÅA, Kazaryan AM, Bjørnbeth BA, Flatmark K, Andersen MH, Tønnessen TI, Bjørnelv GM, Fagerland MW, Kristiansen R, Øyri K, Edwin B (2015)
   Open versus laparoscopic liver resection for colorectal liver metastases (the Oslo-CoMet Study): study protocol for a randomized controlled trial
   Trials, 16, 73
   DOI 10.1186/s13063-015-0577-5, PubMed 25872027
5. Fromm B, Trelis M, Hackenberg M, Cantalapiedra F, Bernal D, Marcilla A (2015)
   The revised microRNA complement of Fasciola hepatica reveals a plethora of overlooked microRNAs and evidence for enrichment of immuno-regulatory microRNAs in extracellular vesicles
   Int J Parasitol, 45 (11), 697-702
   DOI 10.1016/j.ijpara.2015.06.002, PubMed 26183562
6. Hektoen HH, Flatmark K, Andersson Y, Dueland S, Redalen KR, Ree AH (2015)
   Early increase in circulating carbonic anhydrase IX during neoadjuvant treatment predicts favourable outcome in locally advanced rectal cancer
   BMC Cancer, 15, 543
   DOI 10.1186/s12885-015-1557-6, PubMed 26205955
7. Hektoen HH, Ree AH, Redalen KR, Flatmark K (2015)
   Sulfamate inhibitor S4 influences carbonic anhydrase IX ectodomain shedding in colorectal carcinoma cells
   J Enzyme Inhib Med Chem, 31 (5), 779-86
   DOI 10.3109/14756366.2015.1069286, PubMed 26244271
8. Hoshino A, Costa-Silva B, Shen TL, Rodrigues G, Hashimoto A, Tesic Mark M, Molina H, Kohsaka S, Di Giannatale A, Ceder S, Singh S, Williams C, Soplop N, Uryu K, Pharmer L, King T, Bojmar L, Davies AE, Ararso Y, Zhang T, Zhang H, Hernandez J, Weiss JM, Dumont-Cole VD, Kramer K et al. (2015)
   Tumour exosome integrins determine organotropic metastasis
   Nature, 527 (7578), 329-35
   DOI 10.1038/nature15756, PubMed 26524530
9. Redalen KR, Sitter B, Bathen TF, Grøholt KK, Hole KH, Dueland S, Flatmark K, Ree AH, Seierstad T (2015)
   High tumor glycine concentration is an adverse prognostic factor in locally advanced rectal cancer
   Radiother Oncol, 118 (2), 393-8
   DOI 10.1016/j.radonc.2015.11.031, PubMed 26705680
10. Ree AH, Flatmark K, Saelen MG, Folkvord S, Dueland S, Geisler J, Redalen KR (2015)
    Tumor phosphatidylinositol 3-kinase signaling in therapy resistance and metastatic dissemination of rectal cancer: opportunities for signaling-adapted therapies
    Crit Rev Oncol Hematol, 95 (1), 114-24
    DOI 10.1016/j.critrevonc.2015.01.003, PubMed 25624177
11. Repetto-Llamazares AH, Larsen RH, Patzke S, Fleten KG, Didierlaurent D, Pichard A, Pouget JP, Dahle J (2015)
    Targeted Cancer Therapy with a Novel Anti-CD37 Beta-Particle Emitting Radioimmunoconjugate for Treatment of Non-Hodgkin Lymphoma
    PLoS One, 10 (6), e0128816
    DOI 10.1371/journal.pone.0128816, PubMed 26066655
12. Seierstad T, Hole KH, Grøholt KK, Dueland S, Ree AH, Flatmark K, Redalen KR (2015)
    MRI volumetry for prediction of tumour response to neoadjuvant chemotherapy followed by chemoradiotherapy in locally advanced rectal cancer
    Br J Radiol, 88 (1051), 20150097
    DOI 10.1259/bjr.20150097, PubMed 25899892
13. Srivastava SK, Bhardwaj A, Arora S, Tyagi N, Singh AP, Carter JE, Scammell JG, Fodstad Ø, Singh S (2015)
    Interleukin-8 is a key mediator of FKBP51-induced melanoma growth, angiogenesis and metastasis
    Br J Cancer, 112 (11), 1772-81
    DOI 10.1038/bjc.2015.154, PubMed 25942396
14. Wendel T, Zhen Y, Suo Z, Bruheim S, Wiedlocha A (2015)
    The novel HSP90 inhibitor NVP-AUY922 shows synergistic anti-leukemic activity with cytarabine in vivo
    Exp Cell Res, 340 (2), 220-6
    DOI 10.1016/j.yexcr.2015.12.017, PubMed 26748184

Publications 2014

1. Haugen MH, Boye K, Nesland JM, Pettersen SJ, Egeland EV, Tamhane T, Brix K, Maelandsmo GM, Flatmark K (2014)
   High expression of the cysteine proteinase legumain in colorectal cancer - implications for therapeutic targeting
   Eur J Cancer, 51 (1), 9-17
   DOI 10.1016/j.ejca.2014.10.020, PubMed 25466510
2. Ingebrigtsen VA, Boye K, Nesland JM, Nesbakken A, Flatmark K, Fodstad Ø (2014)
   B7-H3 expression in colorectal cancer: associations with clinicopathological parameters and patient outcome
   BMC Cancer, 14, 602
   DOI 10.1186/1471-2407-14-602, PubMed 25139714
3. Nygren MK, Tekle C, Ingebrigtsen VA, Mäkelä R, Krohn M, Aure MR, Nunes-Xavier CE, Perälä M, Tramm T, Alsner J, Overgaard J, Nesland JM, Borgen E, Børresen-Dale AL, Fodstad Ø, Sahlberg KK, Leivonen SK (2014)
   Identifying microRNAs regulating B7-H3 in breast cancer: the clinical impact of microRNA-29c
   Br J Cancer, 110 (8), 2072-80
   DOI 10.1038/bjc.2014.113, PubMed 24577056
4. Ree AH, Saelen MG, Kalanxhi E, Østensen IH, Schee K, Røe K, Abrahamsen TW, Dueland S, Flatmark K (2014)
   Biomarkers of histone deacetylase inhibitor activity in a phase 1 combined-modality study with radiotherapy
   PLoS One, 9 (2), e89750
   DOI 10.1371/journal.pone.0089750, PubMed 24587009
5. Wiiger MT, Bideli H, Fodstad O, Flatmark K, Andersson Y (2014)
   The MOC31PE immunotoxin reduces cell migration and induces gene expression and cell death in ovarian cancer cells
   J Ovarian Res, 7, 23
   DOI 10.1186/1757-2215-7-23, PubMed 24528603

Publications 2013

1. Bruheim S, Sandvold ML, Mælandsmo GM, Fodstad O (2013)
   Antitumor activity of elacytarabine combined with bevacizumab, cetuximab and trastuzumab in human NSCLC xenografts
   Anticancer Res, 33 (9), 3615-21
   PubMed 24023287
2. Flatmark K, Guldvik IJ, Svensson H, Fleten KG, Flørenes VA, Reed W, Giercksky KE, Fodstad Ø, Andersson Y (2013)
   Immunotoxin targeting EpCAM effectively inhibits peritoneal tumor growth in experimental models of mucinous peritoneal surface malignancies
   Int J Cancer, 133 (6), 1497-506
   DOI 10.1002/ijc.28158, PubMed 23494569
3. Rud AK, Borgen E, Mælandsmo GM, Flatmark K, Le H, Josefsen D, Solvoll I, Schirmer CB, Helland Å, Jørgensen L, Brustugun OT, Fodstad Ø, Boye K (2013)
   Clinical significance of disseminated tumour cells in non-small cell lung cancer
   Br J Cancer, 109 (5), 1264-70
   DOI 10.1038/bjc.2013.450, PubMed 23942067
4. Schee K, Lorenz S, Worren MM, Günther CC, Holden M, Hovig E, Fodstad O, Meza-Zepeda LA, Flatmark K (2013)
   Deep Sequencing the MicroRNA Transcriptome in Colorectal Cancer
   PLoS One, 8 (6), e66165
   DOI 10.1371/journal.pone.0066165, PubMed 23824282

Publications 2012

1. Boye K, Nesland JM, Sandstad B, Haugland Haugen M, Mælandsmo GM, Flatmark K (2012)
   EMMPRIN is associated with S100A4 and predicts patient outcome in colorectal cancer
   Br J Cancer, 107 (4), 667-74
   DOI 10.1038/bjc.2012.293, PubMed 22782346
2. Ingebrigtsen VA, Boye K, Tekle C, Nesland JM, Flatmark K, Fodstad O (2012)
   B7-H3 expression in colorectal cancer: nuclear localization strongly predicts poor outcome in colon cancer
   Int J Cancer, 131 (11), 2528-36
   DOI 10.1002/ijc.27566, PubMed 22473715
3. Schee K, Boye K, Abrahamsen TW, Fodstad Ø, Flatmark K (2012)
   Clinical relevance of microRNA miR-21, miR-31, miR-92a, miR-101, miR-106a and miR-145 in colorectal cancer
   BMC Cancer, 12, 505
   DOI 10.1186/1471-2407-12-505, PubMed 23121918
4. Schee K, Flatmark K, Holm R, Boye K, Paus E (2012)
   Investigation of nonspecific cross-reacting antigen 2 as a prognostic biomarker in bone marrow plasma from colorectal cancer patients (vol 33, pg 73, 2012)
   Tumor Biol., 33 (4), 1263-1264

Publications 2011

1. Bruheim S, Kristian A, Uenaka T, Suo Z, Tsuruoka A, Nesland JM, Fodstad Ø (2011)
   Antitumour activity of oral E7080, a novel inhibitor of multiple tyrosine kinases, in human sarcoma xenografts
   Int J Cancer, 129 (3), 742-50
   DOI 10.1002/ijc.25922, PubMed 21225632
2. Flatmark K, Borgen E, Nesland JM, Rasmussen H, Johannessen HO, Bukholm I, Rosales R, Hårklau L, Jacobsen HJ, Sandstad B, Boye K, Fodstad Ø (2011)
   Disseminated tumour cells as a prognostic biomarker in colorectal cancer
   Br J Cancer, 104 (9), 1434-9
   DOI 10.1038/bjc.2011.97, PubMed 21448171
3. Risberg K, Fodstad Ø, Andersson Y (2011)
   Synergistic anticancer effects of the 9.2.27PE immunotoxin and ABT-737 in melanoma
   PLoS One, 6 (9), e24012
   DOI 10.1371/journal.pone.0024012, PubMed 21915275
4. Risberg K, Guldvik IJ, Palchaudhuri R, Xi Y, Ju J, Fodstad O, Hergenrother PJ, Andersson Y (2011)
   Triphenylmethyl derivatives enhances the anticancer effect of immunotoxins
   J Immunother, 34 (5), 438-47
   DOI 10.1097/CJI.0b013e31821e00ae, PubMed 21577141
5. Schee K, Flatmark K, Holm R, Boye K, Paus E (2011)
   Investigation of nonspecific cross-reacting antigen 2 as a prognostic biomarker in bone marrow plasma from colorectal cancer patients
   Tumour Biol, 33 (1), 73-83
   DOI 10.1007/s13277-011-0247-5, PubMed 22006279
6. Tekle C, Nygren MK, Chen YW, Dybsjord I, Nesland JM, Maelandsmo GM, Fodstad O (2011)
   B7-H3 contributes to the metastatic capacity of melanoma cells by modulation of known metastasis-associated genes
   Int J Cancer, 130 (10), 2282-90
   DOI 10.1002/ijc.26238, PubMed 21671471
7. Tveito S, Andersen K, Kåresen R, Fodstad Ø (2011)
   Analysis of EpCAM positive cells isolated from sentinel lymph nodes of breast cancer patients identifies subpopulations of cells with distinct transcription profiles
   Breast Cancer Res, 13 (4), R75
   DOI 10.1186/bcr2922, PubMed 21816090

Publications 2010

1. Boye K, Nesland JM, Sandstad B, Mælandsmo GM, Flatmark K (2010)
   Nuclear S100A4 is a novel prognostic marker in colorectal cancer
   Eur J Cancer, 46 (16), 2919-25
   DOI 10.1016/j.ejca.2010.07.013, PubMed 20719498
2. Flatmark K, Davidson B, Kristian A, Stavnes HT, Førsund M, Reed W (2010)
   Exploring the peritoneal surface malignancy phenotype--a pilot immunohistochemical study of human pseudomyxoma peritonei and derived animal models
   Hum Pathol, 41 (8), 1109-19
   DOI 10.1016/j.humpath.2009.12.013, PubMed 20338618
3. Flatmark K, Ree AH (2010)
   Radiosensitizing drugs: lessons to be learned from the oxaliplatin story
   J Clin Oncol, 28 (29), e577-8; author reply e581-3
   DOI 10.1200/JCO.2010.30.0921, PubMed 20733124
4. Paus E, Haugen MH, Olsen KH, Flatmark K, Maelandsmo GM, Nilsson O, Röijer E, Lundin M, Fermér C, Samsonova M, Lebedin Y, Stigbrand T (2010)
   TD-11 workshop report: characterization of monoclonal antibodies to S100 proteins
   Tumour Biol, 32 (1), 1-12
   DOI 10.1007/s13277-010-0073-1, PubMed 20652782
5. Prasmickaite L, Skrbo N, Høifødt HK, Suo Z, Engebråten O, Gullestad HP, Aamdal S, Fodstad Ø, Maelandsmo GM (2010)
   Human malignant melanoma harbours a large fraction of highly clonogenic cells that do not express markers associated with cancer stem cells
   Pigment Cell Melanoma Res, 23 (3), 449-51
   DOI 10.1111/j.1755-148X.2010.00690.x, PubMed 20236249
6. Risberg K, Fodstad O, Andersson Y (2010)
   Immunotoxins: a promising treatment modality for metastatic melanoma?
   Ochsner J, 10 (3), 193-9
   PubMed 21603377
7. Risberg K, Fodstad O, Andersson Y (2010)
   Anti-melanoma activity of the 9.2.27PE immunotoxin in dacarbazine resistant cells
   J Immunother, 33 (3), 272-8
   DOI 10.1097/CJI.0b013e3181c54991, PubMed 20445347
8. Schee K, Fodstad Ø, Flatmark K (2010)
   MicroRNAs as biomarkers in colorectal cancer
   Am J Pathol, 177 (4), 1592-9
   DOI 10.2353/ajpath.2010.100024, PubMed 20829435
9. Sørensen O, Andersen A, Olsen H, Alexandr K, Ekstrøm PO, Giercksky KE, Flatmark K (2010)
   Validation and use of microdialysis for determination of pharmacokinetic properties of the chemotherapeutic agent mitomycin C - an experimental study
   BMC Cancer, 10, 469
   DOI 10.1186/1471-2407-10-469, PubMed 20809961
10. Wiiger MT, Gehrken HB, Fodstad Ø, Maelandsmo GM, Andersson Y (2010)
    A novel human recombinant single-chain antibody targeting CD166/ALCAM inhibits cancer cell invasion in vitro and in vivo tumour growth
    Cancer Immunol Immunother, 59 (11), 1665-74
    DOI 10.1007/s00262-010-0892-3, PubMed 20635083

Publications 2009

1. Bruheim S, Xi Y, Ju J, Fodstad O (2009)
   Gene expression profiles classify human osteosarcoma xenografts according to sensitivity to doxorubicin, cisplatin, and ifosfamide
   Clin Cancer Res, 15 (23), 7161-9
   DOI 10.1158/1078-0432.CCR-08-2816, PubMed 19920113
2. Hoyem S, Bruheim S, Maelandsmo G, Standal M, Olberg DE, Brudeli B, Asberg A, Klaveness J, Rongved P (2009)
   Didanosine ester prodrugs: Synthesis, albumin binding properties and pharmacokinetic studies in rats (vol 44, pg 3874, 2009)
   Eur. J. Med. Chem., 44 (11), 4786
3. Risberg K, Fodstad Ø, Andersson Y (2009)
   The melanoma specific 9.2.27PE immunotoxin efficiently kills melanoma cells in vitro
   Int J Cancer, 125 (1), 23-33
   DOI 10.1002/ijc.24317, PubMed 19350633

Publications 2008

1. Faye RS, Paus E, Maelandsmo GM, Berner A, Høifødt HK, Fodstad Ø, Aamdal S (2008)
   S100B in bone marrow aspirates in healthy individuals and malignant melanoma patients
   Melanoma Res, 18 (2), 134-40
   DOI 10.1097/CMR.0b013e3282f623d9, PubMed 18337650
2. Kristensen AT, Wiig JN, Larsen SG, Giercksky KE, Ekstrøm PO (2008)
   Molecular detection (k-ras) of exfoliated tumour cells in the pelvis is a prognostic factor after resection of rectal cancer?
   BMC Cancer, 8, 213
   DOI 10.1186/1471-2407-8-213, PubMed 18655729
3. Ree AH, Folkvord S, Flatmark K (2008)
   HDAC2 deficiency and histone acetylation
   Nat Genet, 40 (7), 812-3; author reply 813
   DOI 10.1038/ng0708-812, PubMed 18583969

Publications 2007

1. Flatmark K, Reed W, Halvorsen T, Sørensen O, Wiig JN, Larsen SG, Fodstad Ø, Giercksky KE (2007)
   Pseudomyxoma peritonei--two novel orthotopic mouse models portray the PMCA-I histopathologic subtype
   BMC Cancer, 7, 116
   DOI 10.1186/1471-2407-7-116, PubMed 17603904
2. Fodstad Ø (2007)
   [The 75th anniversary of the Radium Hospital]
   Tidsskr Nor Laegeforen, 127 (13), 1800-1
   PubMed 17599133
3. Tveito S, Maelandsmo GM, Hoifodt HK, Rasmussen H, Fodstad O (2007)
   Specific isolation of disseminated cancer cells: a new method permitting sensitive detection of target molecules of diagnostic and therapeutic value
   Clin Exp Metastasis, 24 (5), 317-27
   DOI 10.1007/s10585-006-9052-8, PubMed 17530423

Publications 2006

1. Andersson Y, Le H, Juell S, Fodstad Ø (2006)
   AMP-activated protein kinase protects against anti-epidermal growth factor receptor-Pseudomonas exotoxin A immunotoxin-induced MA11 breast cancer cell death
   Mol Cancer Ther, 5 (4), 1050-9
   DOI 10.1158/1535-7163.MCT-05-0318, PubMed 16648577
2. Flatmark K, Nome RV, Folkvord S, Bratland A, Rasmussen H, Ellefsen MS, Fodstad Ø, Ree AH (2006)
   Radiosensitization of colorectal carcinoma cell lines by histone deacetylase inhibition
   Radiat Oncol, 1, 25
   DOI 10.1186/1748-717X-1-25, PubMed 16887021

Publications 2005

1. Holthe MR, Andersson Y, Lyberg T (2005)
   Lack of proinflammatory effects of free fatty acids on human umbilical cord vein endothelial cells and leukocytes
   Acta Obstet Gynecol Scand, 84 (7), 672-8
   DOI 10.1111/j.0001-6349.2005.00799.x, PubMed 15954878

Publications 2004

1. Andersson Y, Juell S, Fodstad Ø (2004)
   Downregulation of the antiapoptotic MCL-1 protein and apoptosis in MA-11 breast cancer cells induced by an anti-epidermal growth factor receptor-Pseudomonas exotoxin a immunotoxin
   Int J Cancer, 112 (3), 475-83
   DOI 10.1002/ijc.20371, PubMed 15382075
2. Bruheim S, Bruland OS, Breistol K, Maelandsmo GM, Fodstad O (2004)
   Human osteosarcoma xenografts and their sensitivity to chemotherapy
   Pathol Oncol Res, 10 (3), 133-41
   DOI 10.1007/BF03033741, PubMed 15448748
3. Flatmark K, Maelandsmo GM, Martinsen M, Rasmussen H, Fodstad Ø (2004)
   Twelve colorectal cancer cell lines exhibit highly variable growth and metastatic capacities in an orthotopic model in nude mice
   Eur J Cancer, 40 (10), 1593-8
   DOI 10.1016/j.ejca.2004.02.023, PubMed 15196545
4. Flatmark K, Maelandsmo GM, Mikalsen SO, Nustad K, Varaas T, Rasmussen H, Meling GI, Fodstad Ø, Paus E (2004)
   Immunofluorometric assay for the metastasis-related protein S100A4: release of S100A4 from normal blood cells prohibits the use of S100A4 as a tumor marker in plasma and serum
   Tumour Biol, 25 (1-2), 31-40
   DOI 10.1159/000077721, PubMed 15192310

Publications 2003

1. Andersen K, Smith-Sørensen B, Pedersen KB, Hovig E, Myklebost O, Fodstad Ø, Maelandsmo GM (2003)
   Interferon-gamma suppresses S100A4 transcription independently of apoptosis or cell cycle arrest
   Br J Cancer, 88 (12), 1995-2001
   DOI 10.1038/sj.bjc.6600998, PubMed 12799648
2. Flatmark K, Pedersen KB, Nesland JM, Rasmussen H, Aamodt G, Mikalsen SO, Bjørnland K, Fodstad Ø, Maelandsmo GM (2003)
   Nuclear localization of the metastasis-related protein S100A4 correlates with tumour stage in colorectal cancer
   J Pathol, 200 (5), 589-95
   DOI 10.1002/path.1381, PubMed 12898594
3. Guren TK, Ødegård J, Abrahamsen H, Thoresen GH, Susa M, Andersson Y, Østby E, Christoffersen T (2003)
   EGF receptor-mediated, c-Src-dependent, activation of Stat5b is downregulated in mitogenically responsive hepatocytes
   J Cell Physiol, 196 (1), 113-23
   DOI 10.1002/jcp.10282, PubMed 12767047
4. Kristensen AT, Bjørheim J, Wiig J, Giercksky KE, Ekstrøm PO (2003)
   DNA variants in the ATM gene are not associated with sporadic rectal cancer in a Norwegian population-based study
   Int J Colorectal Dis, 19 (1), 49-54
   DOI 10.1007/s00384-003-0519-7, PubMed 12827413

Publications 2002

1. Flatmark K, Bjørnland K, Johannessen HO, Hegstad E, Rosales R, Hårklau L, Solhaug JH, Faye RS, Søreide O, Fodstad Ø, Study Group for Micrometastases in BM in Colorectal Cancer (2002)
   Immunomagnetic detection of micrometastatic cells in bone marrow of colorectal cancer patients
   Clin Cancer Res, 8 (2), 444-9
   PubMed 11839662
2. Pedersen KB, Nesland JM, Fodstad Ø, Maelandsmo GM (2002)
   Expression of S100A4, E-cadherin, alpha- and beta-catenin in breast cancer biopsies
   Br J Cancer, 87 (11), 1281-6
   DOI 10.1038/sj.bjc.6600624, PubMed 12439718

Publications 2001

1. Fodstad O, Faye R, Høifødt HK, Skovlund E, Aamdal S (2001)
   Immunobead-based detection and characterization of circulating tumor cells in melanoma patients
   Recent Results Cancer Res, 158, 40-50
   DOI 10.1007/978-3-642-59537-0_5, PubMed 11092032